-
1
-
-
0037137593
-
Tumor-derived exosomes: a new source of tumor rejection antigens
-
PID: 12477425
-
André F, Schartz NEC, Chaput N, Flament C, Raposo G, Amigorena S, Angevin E, Zitvogel L (2002a) Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine 20:A28–A31
-
(2002)
Vaccine
, vol.20
, pp. A28-A31
-
-
André, F.1
Schartz, N.E.C.2
Chaput, N.3
Flament, C.4
Raposo, G.5
Amigorena, S.6
Angevin, E.7
Zitvogel, L.8
-
2
-
-
0037183242
-
Malignant effusions and immunogenic tumour-derived exosomes
-
PID: 12147373
-
André F, Schartz NEC, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L (2002b) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360:295–305
-
(2002)
Lancet
, vol.360
, pp. 295-305
-
-
André, F.1
Schartz, N.E.C.2
Movassagh, M.3
Flament, C.4
Pautier, P.5
Morice, P.6
Pomel, C.7
Lhomme, C.8
Escudier, B.9
Le Chevalier, T.10
Tursz, T.11
Amigorena, S.12
Raposo, G.13
Angevin, E.14
Zitvogel, L.15
-
3
-
-
85016850616
-
Whole tumor antigen vaccines: where are we?
-
PID: 26343191
-
Chiang CL-L, Coukos G, Kandalaft LE (2015) Whole tumor antigen vaccines: where are we? Vaccines 3:344–372
-
(2015)
Vaccines
, vol.3
, pp. 344-372
-
-
Chiang, C.L.-L.1
Coukos, G.2
Kandalaft, L.E.3
-
4
-
-
84943329717
-
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
-
PID: 26389673
-
Cohen CJ, Gartner JJ, Horovitz-Fried M, Shamalov K, Trebska-McGowan K, Bliskovsky VV, Parkhurst MR, Ankri C, Prickett TD, Crystal JS, Li YF, El-Gamil M, Rosenberg SA, Robbins PF (2015) Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes. J Clin Invest 125:3981–3991
-
(2015)
J Clin Invest
, vol.125
, pp. 3981-3991
-
-
Cohen, C.J.1
Gartner, J.J.2
Horovitz-Fried, M.3
Shamalov, K.4
Trebska-McGowan, K.5
Bliskovsky, V.V.6
Parkhurst, M.R.7
Ankri, C.8
Prickett, T.D.9
Crystal, J.S.10
Li, Y.F.11
El-Gamil, M.12
Rosenberg, S.A.13
Robbins, P.F.14
-
5
-
-
41149172340
-
Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer
-
COI: 1:CAS:528:DC%2BD1cXjslCnsbk%3D, PID: 18362931
-
Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G (2008) Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 16:782–790
-
(2008)
Mol Ther
, vol.16
, pp. 782-790
-
-
Dai, S.1
Wei, D.2
Wu, Z.3
Zhou, X.4
Wei, X.5
Huang, H.6
Li, G.7
-
6
-
-
34547766513
-
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity
-
PID: 17557817
-
de Jonge MI, Pehau-Arnaudet G, Fretz MM, Romain F, Bottai D, Brodin P, Honoré N, Marchal G, Jiskoot W, England P, Cole ST, Brosch R (2007) ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol 189:6028–6034
-
(2007)
J Bacteriol
, vol.189
, pp. 6028-6034
-
-
de Jonge, M.I.1
Pehau-Arnaudet, G.2
Fretz, M.M.3
Romain, F.4
Bottai, D.5
Brodin, P.6
Honoré, N.7
Marchal, G.8
Jiskoot, W.9
England, P.10
Cole, S.T.11
Brosch, R.12
-
7
-
-
84871752747
-
Mycobacterium tuberculosis ESAT-6 exhibits a unique membrane-interacting activity that is not found in its ortholog from non-pathogenic Mycobacterium smegmatis
-
PID: 23150662
-
de Leon J, Jiang G, Ma Y, Rubin E, Fortune S, Sun J (2012) Mycobacterium tuberculosis ESAT-6 exhibits a unique membrane-interacting activity that is not found in its ortholog from non-pathogenic Mycobacterium smegmatis. J Biol Chem 287:44184–44191
-
(2012)
J Biol Chem
, vol.287
, pp. 44184-44191
-
-
de Leon, J.1
Jiang, G.2
Ma, Y.3
Rubin, E.4
Fortune, S.5
Sun, J.6
-
8
-
-
84908251881
-
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
-
PID: 25245761
-
Duan F, Duitama J, Al Seesi S, Ayres CM, Corcelli SA, Pawashe AP, Blanchard T, McMahon D, Sidney J, Sette A, Baker BM, Mandoiu II, Srivastava PK (2014) Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity. J Exp Med 211:2231–2248
-
(2014)
J Exp Med
, vol.211
, pp. 2231-2248
-
-
Duan, F.1
Duitama, J.2
Al Seesi, S.3
Ayres, C.M.4
Corcelli, S.A.5
Pawashe, A.P.6
Blanchard, T.7
McMahon, D.8
Sidney, J.9
Sette, A.10
Baker, B.M.11
Mandoiu, I.I.12
Srivastava, P.K.13
-
9
-
-
84862117665
-
Recent advances on the role of tumor exosomes in immunosuppression and disease progression
-
COI: 1:CAS:528:DC%2BC38XosVKjtbc%3D, PID: 22369922
-
Filipazzi P, Bürdek M, Villa A, Rivoltini L, Huber V (2012) Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 22:342–349
-
(2012)
Semin Cancer Biol
, vol.22
, pp. 342-349
-
-
Filipazzi, P.1
Bürdek, M.2
Villa, A.3
Rivoltini, L.4
Huber, V.5
-
10
-
-
0020531610
-
High efficiency DNA-mediated transformation of primate cells
-
COI: 1:CAS:528:DyaL3sXltFOjtb0%3D, PID: 6306768
-
Gorman C, Padmanabhan R, Howard BH (1983) High efficiency DNA-mediated transformation of primate cells. Science 221:551–553
-
(1983)
Science
, vol.221
, pp. 551-553
-
-
Gorman, C.1
Padmanabhan, R.2
Howard, B.H.3
-
11
-
-
84920921528
-
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
-
COI: 1:CAS:528:DC%2BC2cXitFamsr7N, PID: 25428507
-
Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Toebes M, Vesely MD, Lam SS, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJ, Mardis ER, Gillanders WE, Artyomov MN, Schreiber RD (2014) Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515:577–581
-
(2014)
Nature
, vol.515
, pp. 577-581
-
-
Gubin, M.M.1
Zhang, X.2
Schuster, H.3
Caron, E.4
Ward, J.P.5
Noguchi, T.6
Ivanova, Y.7
Hundal, J.8
Arthur, C.D.9
Krebber, W.J.10
Mulder, G.E.11
Toebes, M.12
Vesely, M.D.13
Lam, S.S.14
Korman, A.J.15
Allison, J.P.16
Freeman, G.J.17
Sharpe, A.H.18
Pearce, E.L.19
Schumacher, T.N.20
Aebersold, R.21
Rammensee, H.G.22
Melief, C.J.23
Mardis, E.R.24
Gillanders, W.E.25
Artyomov, M.N.26
Schreiber, R.D.27
more..
-
12
-
-
84857170293
-
Antitumor effect of chondroitin sulfate-coated ternary granulocyte macrophage-colony-stimulating factor plasmid complex for ovarian cancer
-
COI: 1:CAS:528:DC%2BC38XisFars70%3D, PID: 22228506
-
Hamada K, Yoshihara C, Ito T, Tani K, Tagawa M, Sakuragawa N, Itoh H, Koyama Y (2012) Antitumor effect of chondroitin sulfate-coated ternary granulocyte macrophage-colony-stimulating factor plasmid complex for ovarian cancer. J Gene Med 14:120–127
-
(2012)
J Gene Med
, vol.14
, pp. 120-127
-
-
Hamada, K.1
Yoshihara, C.2
Ito, T.3
Tani, K.4
Tagawa, M.5
Sakuragawa, N.6
Itoh, H.7
Koyama, Y.8
-
13
-
-
43049093363
-
Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid
-
COI: 1:CAS:528:DC%2BD1cXlt1agtLs%3D, PID: 18446606
-
Ito T, Yoshihara C, Tanaka NI, Koyama Y (2008) Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid. J Drug Target 16:276–281
-
(2008)
J Drug Target
, vol.16
, pp. 276-281
-
-
Ito, T.1
Yoshihara, C.2
Tanaka, N.I.3
Koyama, Y.4
-
14
-
-
75449101757
-
DNA/polyethylenimine/hyaluronic acid small complex particles and tumor suppression in mice
-
COI: 1:CAS:528:DC%2BC3cXht1yisLY%3D, PID: 20047759
-
Ito T, Yoshihara C, Hamada K, Koyama Y (2010) DNA/polyethylenimine/hyaluronic acid small complex particles and tumor suppression in mice. Biomaterials 31:2912–2918
-
(2010)
Biomaterials
, vol.31
, pp. 2912-2918
-
-
Ito, T.1
Yoshihara, C.2
Hamada, K.3
Koyama, Y.4
-
15
-
-
84890551231
-
Preparation of calcium phosphate nanocapsule including deoxyribonucleic acid-polyethyleneimine-hyaluronic acid ternary complex for durable gene delivery
-
COI: 1:CAS:528:DC%2BC3sXhslWjtL7K, PID: 24186653
-
Ito T, Koyama Y, Otsuka M (2014) Preparation of calcium phosphate nanocapsule including deoxyribonucleic acid-polyethyleneimine-hyaluronic acid ternary complex for durable gene delivery. J Pharm Sci 103:179–184
-
(2014)
J Pharm Sci
, vol.103
, pp. 179-184
-
-
Ito, T.1
Koyama, Y.2
Otsuka, M.3
-
16
-
-
33645314949
-
Exosomes biological significance: a concise review
-
COI: 1:CAS:528:DC%2BD28XivVGrtr0%3D, PID: 16487731
-
Johnstone RM (2006) Exosomes biological significance: a concise review. Blood Cells Mol Dis 36:315–321
-
(2006)
Blood Cells Mol Dis
, vol.36
, pp. 315-321
-
-
Johnstone, R.M.1
-
17
-
-
84938404355
-
Novel antitumor strategy utilizing a plasmid expressing a Mycobacterium tuberculosis antigen as a “danger signal” to block immune escape of tumor cells
-
PID: 26213962
-
Koyama Y, Yoshihara C, Ito T (2015a) Novel antitumor strategy utilizing a plasmid expressing a Mycobacterium tuberculosis antigen as a “danger signal” to block immune escape of tumor cells. Pharmaceutics 7:165–174
-
(2015)
Pharmaceutics
, vol.7
, pp. 165-174
-
-
Koyama, Y.1
Yoshihara, C.2
Ito, T.3
-
18
-
-
84938354997
-
Highly effective non-viral antitumor gene therapy system comprised of biocompatible small plasmid complex particles consisting of pDNA, anionic polysaccharide, and fully deprotected linear polyethylenimine
-
PID: 26213961
-
Koyama Y, Sugiura K, Yoshihara C, Inaba T, Ito T (2015b) Highly effective non-viral antitumor gene therapy system comprised of biocompatible small plasmid complex particles consisting of pDNA, anionic polysaccharide, and fully deprotected linear polyethylenimine. Pharmaceutics 7:152–164
-
(2015)
Pharmaceutics
, vol.7
, pp. 152-164
-
-
Koyama, Y.1
Sugiura, K.2
Yoshihara, C.3
Inaba, T.4
Ito, T.5
-
19
-
-
0034467028
-
Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice
-
COI: 1:CAS:528:DC%2BD3MXisFyrsbg%3D, PID: 11251381
-
Ledwith BJ, Manam S, Troilo PJ, Barnum AB, Pauley CJ, Griffiths TG 2nd, Harper LB, Beare CM, Bagdon WJ, Nichols WW (2000) Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice. Intervirology 43:258–272
-
(2000)
Intervirology
, vol.43
, pp. 258-272
-
-
Ledwith, B.J.1
Manam, S.2
Troilo, P.J.3
Barnum, A.B.4
Pauley, C.J.5
Griffiths, T.G.6
Harper, L.B.7
Beare, C.M.8
Bagdon, W.J.9
Nichols, W.W.10
-
20
-
-
34249012130
-
Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages
-
COI: 1:CAS:528:DC%2BD2sXlsVSrsLk%3D, PID: 17486091
-
Pathak SK, Basu S, Basu KK, Banerjee A, Pathak S, Bhattacharyya A, Kaisho T, Kundu M, Basu J (2007) Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol 8:610–618
-
(2007)
Nat Immunol
, vol.8
, pp. 610-618
-
-
Pathak, S.K.1
Basu, S.2
Basu, K.K.3
Banerjee, A.4
Pathak, S.5
Bhattacharyya, A.6
Kaisho, T.7
Kundu, M.8
Basu, J.9
-
21
-
-
57349164051
-
Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole
-
COI: 1:CAS:528:DC%2BD1cXhsVOgsrfJ, PID: 18852239
-
Smith J, Manoranjan J, Pan M, Bohsali A, Xu J, Liu J, McDonald KL, Szyk A, LaRonde-LeBlanc N, Gao LY (2008) Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole. Infect Immun 76:5478–5487
-
(2008)
Infect Immun
, vol.76
, pp. 5478-5487
-
-
Smith, J.1
Manoranjan, J.2
Pan, M.3
Bohsali, A.4
Xu, J.5
Liu, J.6
McDonald, K.L.7
Szyk, A.8
LaRonde-LeBlanc, N.9
Gao, L.Y.10
-
22
-
-
34248216649
-
Tumor-released microvesicles as vehicles of immunosuppression
-
COI: 1:CAS:528:DC%2BD2sXksVGlt7o%3D, PID: 17409393
-
Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L (2007) Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 67:2912–2915
-
(2007)
Cancer Res
, vol.67
, pp. 2912-2915
-
-
Valenti, R.1
Huber, V.2
Iero, M.3
Filipazzi, P.4
Parmiani, G.5
Rivoltini, L.6
-
23
-
-
84893873412
-
More efficient induction of antitumor T cell immunity by exosomes from CD40L gene-modified lung tumor cells
-
COI: 1:CAS:528:DC%2BC2cXhtV2lt7k%3D, PID: 24173626
-
Wang J, Wang L, Lin Z, Tao L, Chen M (2014) More efficient induction of antitumor T cell immunity by exosomes from CD40L gene-modified lung tumor cells. Mol Med Rep 9:125–131
-
(2014)
Mol Med Rep
, vol.9
, pp. 125-131
-
-
Wang, J.1
Wang, L.2
Lin, Z.3
Tao, L.4
Chen, M.5
-
24
-
-
20244373139
-
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
-
COI: 1:CAS:528:DC%2BD3MXhvVOksrY%3D, PID: 11231627
-
Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297–303
-
(2001)
Nat Med
, vol.7
, pp. 297-303
-
-
Wolfers, J.1
Lozier, A.2
Raposo, G.3
Regnault, A.4
Théry, C.5
Masurier, C.6
Flament, C.7
Pouzieux, S.8
Faure, F.9
Tursz, T.10
Angevin, E.11
Amigorena, S.12
Zitvogel, L.13
-
25
-
-
34248141586
-
Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells
-
Yang Y, Xiu F, Cai Z, Wang J, Wang Q, Fu Y, Cao X (2007) Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells. J Canc Res Clin Oncol 133:389–399
-
(2007)
J Canc Res Clin Oncol
, vol.133
, pp. 389-399
-
-
Yang, Y.1
Xiu, F.2
Cai, Z.3
Wang, J.4
Wang, Q.5
Fu, Y.6
Cao, X.7
-
26
-
-
79960984966
-
Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model
-
COI: 1:CAS:528:DC%2BC3MXhtV2mtLjI, PID: 21829629
-
Yang C, Kim S-H, Bianco NR, Robbins PD (2011) Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS ONE 6:e22517
-
(2011)
PLoS ONE
, vol.6
-
-
Yang, C.1
Kim, S.-H.2
Bianco, N.R.3
Robbins, P.D.4
-
27
-
-
84855249252
-
Oncolytic plasmid: a novel strategy for tumor immuno-gene therapy
-
COI: 1:CAS:528:DC%2BC38Xis1amtr8%3D, PID: 22740917
-
Yoshihara C, Hamada K, Kuroda M, Koyama Y (2012) Oncolytic plasmid: a novel strategy for tumor immuno-gene therapy. Oncol Lett 3:387–390
-
(2012)
Oncol Lett
, vol.3
, pp. 387-390
-
-
Yoshihara, C.1
Hamada, K.2
Kuroda, M.3
Koyama, Y.4
-
28
-
-
74549132676
-
Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma
-
PID: 19956842
-
Zhang Y, Luo CL, He BC, Zhang JM, Cheng G, Wu XH (2010) Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. Int J Oncol 36:133–140
-
(2010)
Int J Oncol
, vol.36
, pp. 133-140
-
-
Zhang, Y.1
Luo, C.L.2
He, B.C.3
Zhang, J.M.4
Cheng, G.5
Wu, X.H.6
|